These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7472757)

  • 1. Arthritis not immobilization causes bone loss in the carrageenan injection model of inflammatory arthritis.
    Bogoch ER; Moran E; Crowe S; Fornasier V
    J Orthop Res; 1995 Sep; 13(5):777-82. PubMed ID: 7472757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pamidronate prevents bone loss associated with carrageenan arthritis by reducing resorptive activity but not recruitment of osteoclasts.
    Moran EL; Fornasier TL; Bogoch TR
    J Orthop Res; 2000 Nov; 18(6):873-81. PubMed ID: 11192246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juxtaarticular bone loss in experimental inflammatory arthritis.
    Bogoch E; Gschwend N; Bogoch B; Rahn B; Perren S
    J Orthop Res; 1988; 6(5):648-56. PubMed ID: 3404321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healing of cancellous bone osteotomy in rabbits--Part II: Local reversal of arthritis-induced osteopenia after osteotomy.
    Bogoch E; Gschwend N; Rahn B; Moran E; Perren S
    J Orthop Res; 1993 Mar; 11(2):292-8. PubMed ID: 8483042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate (pamidronate/APD) prevents arthritis-induced loss of fracture toughness in the rabbit femoral diaphysis.
    Bellingham CM; Lee JM; Moran EL; Bogoch ER
    J Orthop Res; 1995 Nov; 13(6):876-80. PubMed ID: 8544024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractal dimension as a measure of altered trabecular bone in experimental inflammatory arthritis.
    Caldwell CB; Moran EL; Bogoch ER
    J Bone Miner Res; 1998 Jun; 13(6):978-85. PubMed ID: 9626629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uniformity of resorptive bone loss induced by disuse.
    Gross TS; Rubin CT
    J Orthop Res; 1995 Sep; 13(5):708-14. PubMed ID: 7472749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zoledronate (CGP 42'446), a bisphosphonate, protects against metaphyseal intracortical defects in experimental inflammatory arthritis.
    Pysklywec MW; Moran EL; Bogoch ER
    J Orthop Res; 1997 Nov; 15(6):858-61. PubMed ID: 9497810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
    Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
    Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial chondroprotective effect of zoledronate in a rabbit model of inflammatory arthritis.
    Podworny NV; Kandel RA; Renlund RC; Grynpas MD
    J Rheumatol; 1999 Sep; 26(9):1972-82. PubMed ID: 10493679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone ingrowth to implant surfaces in an inflammatory arthritis model.
    An YH; Friedman RJ; Jiang M; LaBreck JC; Draughn RA; Butehorn HF; Bauer TW
    J Orthop Res; 1998 Sep; 16(5):576-84. PubMed ID: 9820281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis.
    Saidenberg-Kermanac'h N; Corrado A; Lemeiter D; deVernejoul MC; Boissier MC; Cohen-Solal ME
    Bone; 2004 Nov; 35(5):1200-7. PubMed ID: 15542046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a bisphosphonate on bone histomorphometry and dynamics in the canine cruciate deficiency model of osteoarthritis.
    Myers SL; Brandt KD; Burr DB; O'Connor BL; Albrecht M
    J Rheumatol; 1999 Dec; 26(12):2645-53. PubMed ID: 10606377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in bone micro-architecture and bone mineral density following experimental osteonecrosis of femoral head by local injection of ethanol in canines].
    Li H; Zhang C; Zeng B
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Mar; 22(3):281-9. PubMed ID: 18396703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological effects of tiludronate in horses after long-term immobilization.
    Delguste C; Amory H; Doucet M; Piccot-Crézollet C; Thibaud D; Garnero P; Detilleux J; Lepage OM
    Bone; 2007 Sep; 41(3):414-21. PubMed ID: 17604709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Articular damage is associated with intraosseous inflammation in the subchondral bone marrow of joints affected by experimental inflammatory arthritis and is modified by zoledronate treatment.
    Bogoch ER; Lee TC; Fornasier VL; Berger SA
    J Rheumatol; 2007 Jun; 34(6):1229-40. PubMed ID: 17516617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraosseous infusion of prostaglandin E2 prevents disuse-induced bone loss in the tibia.
    Welch RD; Ashman RB; Baker KJ; Browne RH
    J Orthop Res; 1996 Mar; 14(2):303-10. PubMed ID: 8648510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in cross-sectional geometry of the distal femoral metaphysis associated with inflammatory arthritis are reduced by a bisphosphonate (zoledronate).
    Pysklywec MW; Moran EL; Bogoch ER
    J Orthop Res; 2000 Sep; 18(5):734-8. PubMed ID: 11117294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of immobilization on the physical properties of cancellous bone: an experimental study].
    Chen XZ
    Zhonghua Wai Ke Za Zhi; 1990 Feb; 28(2):72-6, 125. PubMed ID: 2364826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of swimming training and free mobilization on bone mineral densities of rats with the immobilization-induced osteopenia.
    Karatosun H; Erdogan A; Yildiz M; Akgun C; Cetin C
    Saudi Med J; 2006 Mar; 27(3):312-6. PubMed ID: 16532089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.